GH.NASDAQGuardant Health, INC
Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On January 31, 2025, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 154 restricted stock units vested and were converted into 154 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Krognes directly owns 10,374 shares of common stock and 2,623 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions, indicating a neutral sentiment.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in the director's holdings.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant |
| 06/30/2023 | Date when 25% of the restricted stock units vested |
| 01/31/2025 | Date of transaction: vesting and conversion of restricted stock units |
| 02/03/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.